Pharma BD Deal Intelligence
Dow Pharma gave Valeant/Bausch a durable, if far-from-blockbuster, dermatology franchise anchored by Jublia — a real return on a small deal, just nowhere near the $300-800M peak-sales projection.
Full analysis, sources & comparables →Valeant to acquire Dow Pharmaceutical Sciences for $285M, adding Acanya (newly FDA-approved acne combination) and a robust dermatology pipeline to bolster its…
Pearson described the deal as growing Valeant's scale and capabilities in dermatology, noting Dow's team had supported ten FDA dermatology approvals across…
Valeant Pharmaceuticals International completes acquisition of Dow Pharmaceutical Sciences, effective December 31, 2008, strengthening its U.S. dermatology…
Source summaries from our enrichment pipeline; follow links for originals.
All 6 sources with sentiment breakdown →
Valeant Pharmaceuticals acquired Dow Pharmaceutical Sciences, a dermatology specialty firm, for ~$285M to strengthen its US dermatology franchise. Remove the 'Source:' clause and erroneous Mylan reference.
Dow Pharma gave Valeant/Bausch a durable, if far-from-blockbuster, dermatology franchise anchored by Jublia — a real return on a small deal, just nowhere near the $300-800M peak-sales projection.
Assessment window: 15yr post-close.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Valeant Pharmaceuticals International, Inc. / Dow Pharmaceutical Sciences, Inc. (this deal) | 2009 | $285M | 66 |
| Valeant Pharmaceuticals International, Inc. / iNova Pharmaceuticals | 2011 | $700M | 63 |
| Valeant Pharmaceuticals International, Inc. / Xcel Pharmaceuticals, Inc. | 2005 | $280M | 42 |
| Valeant Pharmaceuticals International, Inc. / Dermik Laboratories (Sanofi dermatology unit) | 2011 | $425M | 36 |
| Valeant Pharmaceuticals International, Inc. / Bausch + Lomb | 2013 | $8.7B | 36 |
| Valeant Pharmaceuticals International, Inc. / Medicis Pharmaceutical Corporation | 2012 | $2.6B | 33 |
| Valeant Pharmaceuticals International, Inc. / PreCision Dermatology, Inc. | 2014 | $475M | 23 |
← Browse all deals · How we score deals
More: 2009 deals · Valeant Pharmaceuticals International, Inc. deals